SHC
Sotera Health Company
Diagnostics & Research · Healthcare · United States
19.02
close · 2026-08-13
value
74
cheaper than peers74
quality
54
stronger fundamentals54
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 12.65× | 97 |
| forward P/E | 17.70× | 87 |
| price to sales | 4.45× | 57 |
| price to book | 8.15× | 33 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 38.0% | 98 |
| return on equity | 27.8% | 83 |
| revenue growth | 9.2% | 30 |
| debt to equity | 340.7% | 2 |
4 of 4 measures available
Facts
| market cap | $5B |
| free cash flow | $154.0M |
| employees | 3,000 |
| first trade | 2020-11-20 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |